Nasdaq
CLDX
Celldex Therapeutics, Inc.
- Health Care
- 1 day
- +1.2%
- 1 month
- +4.1%
- 1 year
- +93.8%
$41.56 · Mkt cap $3.26B
At the 6 Aug 2026 close
Nasdaq
Celldex Therapeutics, Inc.
$41.56 · Mkt cap $3.26B
At the 6 Aug 2026 close
Celldex Therapeutics, Inc. trades under the ticker CLDX on Nasdaq, in the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances). Its market capitalisation is $3.26B. The last closing price was $41.56, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +93.8%, and +4.1% over the past month. Returns are price returns and exclude dividends.
This page exists because CLDX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.